❗ Join 2 experts on MedscapeCME as they discuss how COVID-19 variants have impacted treatments & how to promote equity in COVID-19 treatment and care. COVID19 MedEd MedTwitter 🌐 This CME was developed through a partnership with NHMAmd. 🖥️
This activity is intended for primary care physicians, ID/HIV specialists, and emergency medicine physicians.
The goal of this activity is for the learner to better understand the impact of current SARS-CoV-2 variants on treatments for COVID-19 and improve accessibility of recommended treatments to communities disproportionately affected by COVID-19.Current SARS-CoV-2 variants and their impact on treatments for COVID-19
Strategies to improve accessibility of recommended treatments to communities disproportionately affected by COVID-19Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.Division of Infectious DiseasesThe opinions expressed are those of Dr Paulina A. Rebolledo and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Paulina A.